On March 16, 2018, Health Canada has notified the International Rice
Research Institute (IRRI) that it has no objection to the food use of
Provitamin A Biofortified Rice Event GR2E, more commonly known as Golden
Rice. The decision coincides with the approval from Food Standards Australia
New Zealand (FSANZ) in December 2017.

In their announcement, Health Canada said that "the changes made in this
rice variety did not pose a greater risk to human health than rice varieties
currently available on the Canadian market." In addition, Health Canada also
concluded that GR2E would have no impact on alleries, and that there were no
differences in the nutritional value of GR2E compared to other traditional
rice varieties available for consumption except for increased levels of
provitamin A.

Scientists with expertise in molecular biology, microbiology, toxicology,
chemistry, and nutrition conducted a thorough analysis of the data and the
protocols provided by IRRI to ensure the validity of the results. Health
Canada conducted a comprehensive assessment of Golden Rice according to its
Guidelines for the Safety Assessment of Novel Foods. Their approach in the
safety assessment of GM foods is based upon scientific principles developed
through expert international consultation over the last 20 years with
agencies such as the World Health Organization (WHO), the Food and
Agriculture Organization of the United Nations (FAO), and the Organization
for Economic Co-operation and Development (OECD). This approach is also
currently applied by regulatory agencies around the world in countries such
as the European Union, Australia/New Zealand, Japan, and theUnited States.

[www.canada.ca]
odified-foods-other-novel-foods/approved-products/novel-food-information-gol
den-rice-gr2e.html